ETN vs MRK: Which Is the Better Buy?
Side-by-side comparison of Eaton Corporation plc and Merck & Co., Inc. — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-08-06.
Eaton Corporation plc · Industrials
$447.28
-9.5% upside to fair value
Med Conviction
Grade C+
VS
Merck & Co., Inc. · Healthcare
$113.87
-12.1% upside to fair value
Grade D
High Quality
QuantHub Verdict
ETN has more upside to fair value
(-9.5%).
MRK trades at a lower forward P/E
(32.0x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
ETN |
MRK |
| Current Price |
$447.28 |
$113.87 |
| Fair Value Estimate |
$405.00 |
$100.14 |
| Upside to Fair Value |
-9.5%
|
-12.1%
|
| Market Cap |
$173.7B |
$281.2B |
| Forward P/E |
33.2x
|
32.0x
|
| EV / EBITDA |
30.0x
|
17.3x
|
| Price / Sales |
5.8x
|
4.3x
|
| Price / FCF |
38.6x
|
19.9x
|
| Revenue Growth YoY |
+21.0%
|
+4.3%
|
| Gross Margin |
35.9%
|
75.9%
|
| Operating Margin |
17.7%
|
27.6%
|
| Return on Equity |
18.9%
|
17.9%
|
| Dividend Yield |
0.98% |
0% |
| FCF Yield |
2.59%
|
5.02%
|
| Analyst Consensus |
Buy
|
Hold
|
Investment Thesis
Eaton is a 115-year-old power management company whose Electrical Americas, Electrical Global and Aerospace segments have become a core beneficiary of the same AI data-center, grid modernization and reshoring supercycle driving GE Vernova and Vertiv. Q2 2026 results were record-setting: revenue of $8.5 billion (up 21% year over year, 14% organic), adjusted EPS of $3.15, and segment margins of 23.…
Merck & Co., Inc. is a leading global healthcare company specializing in pharmaceuticals, vaccines, and animal health products. Its business quality is high, supported by a durable competitive moat anchored in the dominant global position of Keytruda in PD-1/PD-L1 oncology, a strong vaccines portfolio including Gardasil, and scale in R&D and manufacturing. The company benefits from a seasoned lea…
Accumulation Zones
| Metric |
ETN |
MRK |
| Zone Low |
$305.00 |
$75.11 |
| Zone High |
$345.00 |
$85.12 |
| In Buy Zone? |
No
|
No
|